期刊文献+

白介素-1β基因多态性及核因子-κB对精神分裂症首次发病患者血清白介素-1β水平的影响 被引量:11

Effects of interleukin-1β gene polymorphism and nuclear factor-κB activation on IL-1β levels in firstepisode schizophrenia
原文传递
导出
摘要 目的探讨精神分裂症患者白介素-10(IL-1β)基因多态性及核因子-κβ(NF—κβ)对IL-1β水平的影响。方法采用聚合酶链反应-限制性内切酶方法检测161例精神分裂症患者(患者组)和135名正常对照者(对照组)的IL-1β基因-511多态性位点和+3953多态性位点的基因型及等位基因频率;采用酶联免疫吸附法检测IL-1β在患者组和对照组血清中的蛋白表达及外周血单个核细胞(PβMC)NF—κβ活性;采用逆转录-聚合酶链反应方法检测PβMC IL-1βmRNA表达水平。结果(1)IL-1β-511G/A位点的等位基因G与精神分裂症存在名义上的关联(P=0.038,多重检验P=0.240),但+3953G/A多态性与精神分裂症无关联(P〉0.05)。(2)患者组血清IL-1β水平[(25.93±13.30)ng/L]、PBME中IL-1βmRNA(1.30±0.30)表达以及NF-κβ活性[(0.28±0.21)μg/L]均高于对照组[(14.19±7.86)ng/L、0.97±0.27、(0.20±0.17)μg/L;P均〈0.05];携带IL-1β基因-511A/G和+3953A/G位点基因型GA和AA的精神分裂症患者较GG携带者的IL-1β水平明显增高(P〈0.05)。结论精神分裂症患者外周血IL-1β水平的增高参与了疾病的病理生理过程,基因多态性和转录因子NF—κB均对细胞因子的分泌起了-定作用。 Objective To explore the effects of interleukin-1β (IL-1β ) gene polymorphism and nuclear factor-κB on serum IL-1β level in schizophrenia. Methods Amplification of the target site in the IL- 1β gene -511 and +3953 were carried out by polymerase chain reaction (PCR) in 161 patients who met the CCMD-3 diagnostic criteria for schizophrenia and 135 healthy control subjects. The allelic and genotypic types were determined by restriction fragment length polymorphism. The serum IL-1β level and peripheral blood mononuclear cell ( PBMC ) NF-κB activation of 83 patients and 65 healthy control subjects were estimated using commercial enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's instructions. Reverse transcription-polymerase chain reaction (RT-PCR) technique was applied to analyze PBMC mRNA expression of IL-1β. Results It showed a significant increase of the IL-1 [3 -511 allele G in schizophrenia patients as compared to healthy controls. While there were no relation between IL-1β + 3953G/A and schizophrenia. Serum level ( 25.93± 13.30 ) ng,/L and PBMC mRNA expression( 1.30 ±0. 30) of IL-1β and NF-κB activation(0. 28 ± 0. 21 ) Ixg/L in the schizophrenia group were significantly higher than those in the control subjects ( 14. 19± 7.86) ng/L, (0. 97 ± 0. 27 ), (0. 20 ± 0. 17) pog/L respectively (P 〈0. 05). Serum IL-1β levels in the subjects with AA and G/A genotypes were significantly higher than those of the subjects with GG genotype in the IL-1β gene -511 and + 3953 target site. Conclusions The higher serum level of IL-1β in schizophrenia patients may be involved in the pathophysiology of schizophrenia. Gene polymorphism and nuclear factor-κB may be related to the secretion of cytokine.
出处 《中华精神科杂志》 CAS CSCD 北大核心 2012年第1期10-15,共6页 Chinese Journal of Psychiatry
基金 国家自然科学基金资助项目(30870892、30971058、81071090) 卫生部科研基金资助项目(200801009) 河南省基础与前沿研究项目(102300413208)
关键词 精神分裂症 白细胞介素1Β 多态性 限制性片段长度 NF-κB Schizophrenia Interleukin-1 beta Polymorphism, restriction fragment length NF-kappa B
  • 相关文献

参考文献20

  • 1Potvin S, Stip E, Sepehry AA, et al. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry, 2008, 63:801-808.
  • 2Masek K, Slonsky J, Petrovicky, P, et al. Neuroendocrine immune interactions in health and disease. Int Immunopharmacol, 2003, 3 : 1235-1246.
  • 3Wilson AG, Symons JA, McDowe11 TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA, 1997, 94: 3195-3199.
  • 4李文强,张红星,宋学勤,张燕,吕路线.地卓西平马来酸盐致精神分裂症模型大鼠前额皮质核因子-κB及相关细胞因子基因表达分析[J].中华精神科杂志,2009,42(3):172-176. 被引量:3
  • 5Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet, 1997, 24 : 1-8.
  • 6Barak V, Barak Y, Levine J, et al. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol Pharmncol, 1995,6 : 61-69.
  • 7Kim YK, Lee MS, Suh KY. Decreased interleukin-2 production in Korean schizophrenic patients. Biol Psychiatry, 1998,43: 701- 704.
  • 8Soderlund J, Schrtider J, Nordin C, et al. Activation of brain interleukin-lbeta in schizophrenia. Mol Psychiatry, 2009, 14 : 1069-1071.
  • 9Hashimoto M, Ishikawa Y, Yokota S, et al. Action site of circulating interleukin-1 on the rabbit brain. Brain Res, 1991, 540(1-2) : 217-223.
  • 10宋学勤,石玉中,郭素芹,吕路线,赵新喜.精神分裂症偏执型患者血浆及脑脊液白细胞介素2,6及免疫球蛋白G水平的研究[J].中华精神科杂志,2003,36(3):135-138. 被引量:12

二级参考文献38

  • 1宋学勤,赵靖平,吕路线,李文强.首发精神分裂症NF-κB活性与细胞因子mRNA表达及蛋白水平的关系[J].中国神经精神疾病杂志,2007,33(8):455-458. 被引量:4
  • 2Licinio J, Seibyl JP, Altemus M, et al. Elevated CSF levels of intedeukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry, 1993, 150: 1408-1410.
  • 3Knmfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry, 2000, 157: 683-694.
  • 4Schwarz M J, Ackenheil M, Riedel M, et al. Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neurosci Lett,1998, 253: 201-203.
  • 5Besedovsky HO, del Bey A. Immune-neuro-endocrine interactions:facts and hypotheses. Endocr Rev, 1996, 17 : 64-102.
  • 6Maas JW, Bowden CL, Miller AL, et al. Schizophrenia, psychosis,and cerebral spinal fluid homovanillic acid concentrations. Schizophr Bull, 1997,23: 147-154.
  • 7Zalcman S, Green-Johnson JM, Murray L, et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.Brain Res. 1994, 643 : 40-49.
  • 8Rothwell N J, Hopkins SJ. Cytokines and the nervous system II:actions and mechanisms of action. Trends Neurosci, 1995, 18: 130-136.
  • 9Frommberger UH, Bauer J, Haselbauer P, et al. Interleukin-6-(IL-6 ) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neuxosci, 1997,247: 228-233.
  • 10Kim YKI KimL, Lee MS. Relationships between interleukins,neurotransmitters and psychopathology in drug-free male schizophrenica.Schizophr Res, 2000, 44:165-175.

共引文献23

同被引文献121

引证文献11

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部